DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Belperio PS, Shahoumian T, Loomis T. , et al.
Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 treatment-experienced patients with hepatitis C genotypes 1 through 4.
Hepatology 2018;
68 (Suppl.): 142A
We do not assume any responsibility for the contents of the web pages of other providers.